Merck reports ‘positive’ results from Phase 3 ZENITH trial evaluating Winrevair

Published on 26 Nov 2024 on TipRanks · via Yahoo Finance

Merck (MRK) announced positive topline results from the Phase 3 ZENITH study evaluating Winrevair in...

Read the rest of the article

Start tracking your investments with Statfolio

Columbia Threadneedle Investments, an investment management company released its “Columbia Divide...

Insider Monkey · via Yahoo Finance 7 hours ago

Merck (MRK) announced positive topline results from the Phase 3 ZENITH study evaluating Winrevair...

TipRanks · via Yahoo Finance 10 hours ago

Winrevair was approved to treat pulmonary arterial hypertension (PAH), a progressive disorder cau...

Reuters · via Yahoo News 25 Nov 2024

On Monday, Merck & Co Inc (NYSE:MRK) revealed topline results from the Phase 3 ZENITH study evalu...

Benzinga · via Yahoo Finance 25 Nov 2024

We recently compiled a list of the 10 Most Promising Cancer Stocks According to Hedge Funds. In t...

Insider Monkey · via Yahoo Finance 25 Nov 2024

We recently made a list of Goldman Sachs’ Top Growth Investors: 34 Stocks With The Highest...

Insider Monkey · via Yahoo Finance 22 Nov 2024

Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks ...

Zacks · via Yahoo Finance 22 Nov 2024

Merck (MRK) has recently been on Zacks.com's list of the most searched stocks. Therefore, you mig...

Zacks · via Yahoo Finance 22 Nov 2024

U.S. government researchers have found that a widely prescribed asthma drug originally sold by Me...

Reuters · via Yahoo Finance 22 Nov 2024